<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68764">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01844440</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2012/25</org_study_id>
    <nct_id>NCT01844440</nct_id>
  </id_info>
  <brief_title>Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD</brief_title>
  <acronym>HRM RTSIO</acronym>
  <official_title>Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to establish and validate High resolution manometry (HRM) criteria
      for the definition of transient lower esophageal sphincter relaxations (tLESRs) in
      gastroesophageal reflux disease (GERD) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      tLESRs represent the main mechanism of all types of reflux events. Inhibition of transient
      lower esophageal sphincter relaxations (tLESRs) has become one of the most relevant
      therapeutic objectives in patients with reflux symptoms resistant to proton pump inhibitors.
      HRM is the gold standard for detecting and characterizing tLESR, and could be considered as
      part of the pharmacological evaluation of new drugs targeting tLESRs. HRM criteria for the
      objective definition of tLESRs in GERD patients have to be established, as it has been done
      in healthy patients Subjects will undergo impedance / manometry recording with solid-state
      catheter systems, during a 30-min fasting and a 2-hour postprandial periods.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>tLESRs characteristics</measure>
    <time_frame>Inclusion (Day 0)</time_frame>
    <safety_issue>No</safety_issue>
    <description>To characterize tLESRs defined according following criteria:
LES basal pressure (mmHg) defined as LES pressure during relaxation
LES minimum pressure during relaxation
Duration of the LES relaxation (seconds)
Integrated relaxation pressure (4 seconds)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reflux underlying mechanisms</measure>
    <time_frame>Inclusion (Day 0)</time_frame>
    <safety_issue>No</safety_issue>
    <description>To detect every reflux and to determine underlying mechanisms
Transient lower esophageal sphincter relaxations (tLESR)
Low basal LES pressure (free reflux)
Increased abdominal pressure
Swallow
Another mechanism</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>HRM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>High resolution manometry</intervention_name>
    <description>Subjects will undergo impedance / manometry recording with solid-state catheter systems, during a 30-min fasting and a 2-hour postprandial periods.</description>
    <arm_group_label>HRM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 to 75 years old

          -  GERD documented by :

               -  Typical reflux symptoms (heartburn, regurgitations) completely responsive to PPI
                  therapy

               -  And/or erosive esophagitis or Barrett's esophagus at endoscopy

               -  And/or positive pH 24h monitoring (acid exposure time &gt; 5% or positive symptom
                  association indices)

          -  Possibility of easily positioned transnasal catheter

          -  Patients covered by social security

          -  Subjects must provide written, free and informed consent

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  History of digestive or thoracic surgery (except appendicectomy)

          -  Patients unable to stop PPI therapy for 7 days

          -  Subjects unable to provide written consent, including adult under guardianship and
             emergency situation

          -  Simultaneous participation in another study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frank ZERBIB, MD-PhD</last_name>
    <phone>+33 (0)5 56 79 58 06</phone>
    <email>frank.zerbib@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Camille DUCERF</last_name>
    <phone>+33 (0) 5 56 82 10 24</phone>
    <email>camille.ducerf@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service d'hépato-gastroentérologie et oncologie digestive</name>
      <address>
        <city>Bordeaux</city>
        <zip>33075</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mireille SIMON, MD</last_name>
      <phone>+33 (0)5 56 79 58 06</phone>
      <email>mireille.simon@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Frank ZERBIB, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Exploration Fonctionnelle Digestive</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ROMAN Sabine, MD</last_name>
      <phone>+33(0) 4 72 11 01 36</phone>
      <email>sabine.roman@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>ROMAN Sabine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut des Maladies de l'Appareil Digestif (IMAD)</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanislas BRULEY DES VARANNES, PUPH</last_name>
    </contact>
    <investigator>
      <last_name>Stanilas BRULEY DES VARANNES, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 23, 2013</lastchanged_date>
  <firstreceived_date>March 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>tLESR</keyword>
  <keyword>impedance</keyword>
  <keyword>manometry</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
